Introduction {#s1}
============

Cre mediated recombination is a powerful and broadly utilized genetic approach to conditionally delete or express selective genes, and is extensively used to lineage trace distinct progenitor populations during development (reviewed by [@b2]; [@b1]). Transgenic *Nestin-cre* lines of mice have been broadly utilized over the past decade to direct recombination to neural stem cells (NSCs) and intermediate neural progenitor cells (NPCs) ([@b4]). Several independent *Nestin-cre* lines have been generated and published (e.g. [@b8]; [@b15]; [@b12]; [@b3]), but only one ([@b14]) is available through the Jackson laboratories and has been used in numerous studies. Based on early reports by the originating investigator it has been assumed that this line is highly efficient in directing cre-mediated recombination to neural progenitors. Here we tested whether or not the only commercially available line of *Nestin-cre* mice is sufficient for recombination in NSCs and NPCs of the forebrain during embryonic and early postnatal development. For comparison we utilized a knock-in *Emx1^cre^* line that is also broadly used for cre-mediated recombination in NSCs and NPCs of the dorsal telencephalon.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

Animals were used under Institutional Animal Care and Use Committee and North Carolina State University regulations, and were housed in the Laboratory Animal Research facility at the College of Veterinary Medicine. *Nestin-cre* (B6.Cg-*Tg (Nes-cre)1Kln*/J; Jackson Lab, \#003771; on a mixed C57BL/6/SJL background) ([@b14]) and knock-in *Emx1^cre^* mice (B6.129S2-*Emx1^tm1(cre)Krj^*/J; Jackson Lab, \#005628; on a 129S2/SvPas background) ([@b5]) were crossed to mice expressing the reporter genes *tdTomato* (tdTom) (B6.129S6-*Gt (ROSA) 26Sor^tm14\ (CAG-tdTomato)\ Hze^*/J; Jackson Lab, \#007908; on a mixed 129S6/SvEvTac/C57BL/6NCr background) ([@b10]) or *LacZ* (B6.129S4-*Gt (ROSA) 26Sor^tm1Sor^*/J; Jackson Lab, \#003309, on a 129S4/SvJaeSor background) ([@b13]), which are conditionally expressed under a knock-in pCAG promoter into the Rosa locus to track cre-mediated recombination.

For mosaic analyses, *MADM11-TG/GT*:*Nestin-cre* or *MADM11-TG/GT*:*Emx1^cre^* mice were generated using breeding schemes previously described ([@b7]). In brief, *Nestin-cre or Emx1^cre^* mice were first crossed to the *MADM11-GT* line (on a 129X1/SvJ background) and the resulting *MADM11-GT:Nestin-cre or MADM11-GT: Emx1^cre^* mice were then crossed to the *MADM11-TG^+^* mice (also on a 129X1/SvJ background) to generate the *MADM11-TG/GT:Nestin-cre or MADM11-TG/GT:Emx1^cre^* mice for mosaic analyses.

For embryonic analyses, the morning of observed vaginal plug was designated as embryonic day 0.5 (E0.5). Embryos were harvested from time-pregnant females following Avertin overdose (7.5 mg/g body weight), their brain removed and fixed with 4% paraformaldehyde for a minimum of 24 hours prior to processing. New born (P0) mice were anesthetized by hypothermia followed by transcardial perfusion with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS). All mice received a pulse of 5-bromo-2′-deoxyuridine (BrdU, Aldrich; 100 mg/kg body weight via intraperitoneal injections to pregnant females or P0 pups) one hour prior to harvestation.

Tissue processing and imaging {#s2b}
-----------------------------

Following perfusion, brains were removed and sectioned in the sagittal plane at 50 µm on a vibratome (Leica VT 1000 S). Floating sections were immunohistochemically processed using standard procedures with rabbit anti-RFP (Abcam; 1:1000), chicken anti-GFP (Abcam; 1:1000), mouse anti-BrdU (BD Bioscience; 13:1000), rabbit anti-cre (Covance; 1:500), and rabbit anti-PH3 (Millipore; 1:500) antibodies. Immunoreactivity was visualized using Alexafluor conjugatged secondary antibodies (Invitrogen). When needed, sections were counterstained with TO-PRO-3 Iodide (Invitrogen; 1:2000) or DAPI (VECTASHIELD mounting medium, Vector labs) for cytoarchitectonic characterization of sections.

Staining of whole embryos for LacZ was as described previously ([@b11]). For tissue preparation, embryos were cryopreserved within 30% sucrose in 0.1 M PBS overnight at 4°C followed by overnight freezing in tissue freezing medium (Triangle Biomedical Sciences) at −80°C. Embryos were then sectioned at 20 µm on a cryostat (Leica).

Data Analyses {#s2c}
-------------

Percentages of tdTom+ recombined cells in cycling progenitors in various regions/tissues were calculated by dividing numbers of either BrdU+/tdTom+ pulse labeled progenitors, or PH3+/tdTom+ mitotic progenitors, by total number of counted BrdU+ or PH3+ nuclei, respectively (*n* = 3 animals; 5 sections per animal; a total of 225 and 217 PH3+ cells at E12.5 and E14.5 respectively; a total of 789 BrdU+ cells at P0). Significance was determined using Student\'s t-test and all values were expressed as mean ± standard error of the mean (SEM).

Results and Discussion {#s3}
======================

The efficiency of recombination in the central nervous system (CNS) was assessed in multiple reporter lines using the only *Nestin-cre* line of mice that was commercially available at the time of this report ([Fig. 1A](#f01){ref-type="fig"}). Similar to past reports on the same line, we found that *Nestin-cre* mediated recombination commences in the CNS during embryogenesis ([Fig. 1B](#f01){ref-type="fig"}). However, much to our surprise, in mice on a tdTomato (tdTom) reporter background the recombination rate was extremely insufficient in the ventricular (VZ) and subventricular (SVZ) zones of the neocortex during early (E12.5) and mid stages of forebrain development (E14.5) ([Fig. 1B](#f01){ref-type="fig"}). Additional expression analyses using cre-specific antibodies confirmed the observed patterns at the various stages of development ([Fig. 1C](#f01){ref-type="fig"}). High-magnification imaging revealed an extremely low recombination rate in PH3 or BrdU immunoreactive cycling NSCs and NPCs in the E14.5 lateral ganglionic eminence (LGE), olfactory ventricle (OV) and the cerebral cortex (Ctx) ([Fig. 1D](#f01){ref-type="fig"}) (1.3±0.7% at E12.5 and 7.4±4% at E14.5 of PH3+ cells in the VZ and SVZ, respectively; *n* = 3 mice/group). Consistent with these findings, *Nestin-cre* on a different reporter line (Rosa-lacZ) also yielded low levels of reporter activity in the VZ of E12.5 cerebral cortices ([Fig. 1D](#f01){ref-type="fig"}).

![Insufficient rate of recombination in NSCs and NPCs of *Nestin-cre* transgenic mice.\
(**A**) Breeding schemes to generate *Nestin-cre* transgenic mice (Jax: B6.Cg-Tg(Nes-cre)1 Kln/J) on either a *LacZ* or *tdTomato* (tdTom) reporter background. LacZ or tdTom are conditionally expressed under the chicken β-actin promoter, which was knocked into the Rosa locus to track cre-mediated recombination. Two loxP sites flank a STOP codon upstream of the reporter cassettes, preventing reporter expression in the absence of cre-mediated recombination. *Nestin-cre* mediated recombination deletes the stop codon allowing the expression of the reporters. (**B**) Sagittal views of the developing CNS illustrating tdTom reporter expression mediated by *Nestin-cre* at embryonic stages E12.5, E14.5, and at birth (P0). (**C**) Analysis of cre expression at ages corresponding to sections in B, using a cre-specific antibody (green), in combination with tdTom and DAPI (blue). Cre(−) controls were obtained from brains of mice negative for Nestin-cre, but genetically positive for tdTom reporter. (**D**) Laminar pattern of *Nestin-cre* mediated recombination in NSCs and NPCs reported by *LacZ* expression in the E12.5 cerebral cortex. LacZ was predominantly expressed in the preplate (PPL), which consists of postmitotic cells, but not in the VZ, which consists of cycling NSCs. Similar pattern of expression was observed in the E14.5 lateral ganglionic eminence (LGE), olfactory ventricular zone (OV), and the cerebral cortices (Ctx). Each region is depicted in high magnification images of boxed regions marked in 1B. At E14.5, recombined tdTom+ cells in the VZ and SVZ (red, arrows) largely fail to co-label with the markers of cycling NSCs and NPCs in all three regions (PH3, green; BrdU, blue). Recombination in the E14.5 Ctx was dense in the intermediate zone (IZ) and the cortical plate (CP), which largely consists of post-mitotic neurons (MZ, marginal zone; devoid of recombined cells). (**E**) The rate of *Nestin-cre* mediated recombination in NSCs and NPCs reaches high levels at P0, revealed by expression of tdTom in nearly all cells (TO-PRO+, blue) and BrdU immunoreactive progenitors (green; arrows) of the subependymal zone (SEZ) and the rostral migratory stream (RMS). Scale bars: B, 500 µm; C, 30 µm; D, 40 µm; E, 20 µm.](bio-01-12-1200-f01){#f01}

In both reporter backgrounds, the majority of recombined cells were situated in the preplate layer (PPL) of the E12.5 cortex as well as intermediate zone (IZ) and cortical plate (CP) of the E14.5 cortex, suggesting that recombination became sufficient during postmitotic stages of neuronal differentiation ([Fig. 1B--D](#f01){ref-type="fig"}). In contrast, the rate of recombination in NSCs and NPCs increased dramatically in the subependymal zone (SEZ) and the rostral migratory stream (RMS) of newborn (P0) mice ([Fig. 1B,E](#f01){ref-type="fig"}). Nearly every BrdU-labeled NSC and NPC expressed tdTom (93±5% of BrdU+) ([Fig. 1E](#f01){ref-type="fig"}), suggesting sufficient *Nestin-cre* mediated recombination in these cells. These findings suggest a gradual increase in the rate of *Nestin-cre* mediated recombination during perinatal development in NSCs and NPCs.

For comparison we utilized a knock-in *Emx1^cre^* line of mice ([Fig. 2A](#f02){ref-type="fig"}) that has been reported to drive sufficient recombination in dorsal telencephalic NSCs and NPCs ([@b5]). In contrast to the *Nestin-cre* line, *Emx1^cre^* mediated recombination was sufficient in the VZ/SVZ of the developing cortex at both E12.5 and E14.5 ([Fig. 2B](#f02){ref-type="fig"}), which we confirmed again using antibody staining for cre ([Fig. 2C](#f02){ref-type="fig"}). In addition, robust recombination was found in the majority (83±8%) of PH3+ progenitors in the E12.5 VZ and SVZ of the cortex ([Fig. 2D](#f02){ref-type="fig"}). The efficiency increased to nearly 100% by E14.5 ([Fig. 2D](#f02){ref-type="fig"}). Thus, the low degree of recombination in *Nestin-cre* brains is not due to potential issues associated with cre-loxP interactions in embryonic progenitors, but is most likely related to the transgene in this specific strain.

![Sufficient rate of recombination in embryonic NSCs and NPCs of Emx1*^cre^* knock-in mice.\
(**A**) Breeding schemes to generate mice with the *Emx1^cre^* locus on the *tdTom* reporter background. (**B**) tdTom reporter expression (red) in the E12.5 and E14.5 *Emx1^cre^* brains. Robust tdTom expression was detected in the entire cortex at both E12.5 and E14.5. (**C**) Analysis of cre expression at ages corresponding to sections in B, using a cre-specific antibody (green), in combination with tdTom and DAPI (blue). Cre(−) controls were obtained from brains of mice negative for *Emx1^cre^*, but genetically positive for tdTom reporter. (**D**) Emx1*^cre^* recombination in neural progenitors of E14.5 cortex (high magnification for the box region indicated in 2B). Emx1*^cre^* mediated tdTom expression (red) was found in the entire cortex including the proliferative VZ and SVZ. High magnification of the VZ regions (box) revealed robust co-localization of PH3+ mitotic NSCs (green) with tdTom (red). Scale bars: B, 300 µm; C, 30 µm; D, low mag (left), 20 µm; high mag (right panels), 10 µm.](bio-01-12-1200-f02){#f02}

To conclusively confirm our surprising findings on the developmental patterns of cre-mediated recombination in NSCs and NPCs in the *Nestin-cre* lines, and to rule out possible recombinogenic issues related to the Rosa locus in the reporter lines in the first part of the study, we crossed both cre lines into the Mosaic Analysis with Double Markers on chromosome 11 (MADM-11) line of mice ([@b7]). In this line, cre-dependent mitotic recombination results in expression of GFP or tdTom independently or together resulting in various cells with three potential expression patterns ([Fig. 3A](#f03){ref-type="fig"}, red, green, yellow). Recombination can also occur in postmitotic cells during the G0 phase, but in this case only cells expressing both GFP and tdTom (yellow cells) will be obtained ([Fig. 3A](#f03){ref-type="fig"}). Using this strategy we found recombined cells with all three colors (red, green, yellow) throughout all layers of the cerebral cortices in *Emx1^cre^ MADM11* brains at E12.5 ([Fig. 3B](#f03){ref-type="fig"}). In addition, recombined NSCs and NPCs were co-labeled with the mitosis marker PH3 in the VZ region ([Fig. 3B](#f03){ref-type="fig"}). Thus, the *Emx1^cre^* knock-in allele is sufficient for driving mitotic recombination in NSCs and NPCs as early as E12.5.

![Analysis of mitotic and post-mitotic specificity of recombination in the cerebral cortices of Emx1^cre^ and Nestin-cre mice using the MADM-11 genetic system.\
(**A**) Scheme of cre-induced reporter expression in Mosaic Analysis with Double Markers on chromosome 11 (MADM-11) mice. In this line, cre-dependent mitotic recombination results in expression of GFP or tdTom independently or together yielding various cells with three potential expression patterns (tdTom+, red; GFP+, green; tdTom+/GFP+, yellow). Recombination can also occur in postmitotic cells during G0, but only yellow cells will be obtained due to the presence of only one allele for each reporter system. (**B**) MADM-11 recombined cells in E12.5 *Nestin-cre* and *Emx1^cre^* cerebral cortices. Only a few *Nestin-cre:MADM11* cells were detected predominantly in the preplate (PPL) away from the VZ. Almost all recombined *Nestin-cre:MADM-11* cells were negative for the mitotic marker PH3 (blue). In contrast, the Emx1*^cre^* knock-in allele was sufficient for driving mitotic recombination in the cerebral cortices at E12.5 as evidenced by the presence of cells expressing a single reporter. Co-localization of PH3 (blue) with recombined cells was detectable in the VZ (arrows). (**C**) *Nestin-cre:MADM-11* recombined cells in E14.5 and E17.5 cerebral cortices. By E14.5, a few mitotically recombined cells were found in the IZ and CP, but very few clones could be detected in the VZ and SVZ. In addition, the majority of recombined cells in the VZ and SVZ were largely devoid of PH3 immunolabeling. By E17.5, mitotic recombination became sufficient in the entire cerebral cortex and PH3+ recombined cells could be readily detected in both the VZ and SVZ (arrows). Scale bars: B, 30 µm; C, 60 µm.](bio-01-12-1200-f03){#f03}

In contrast to the *Emx1^cre^* line, *Nestin-cre* mediated recombination in the MADM-11 background was extremely infrequent in the cerebral cortices at E12.5, and the few recombined cells failed to co-label with PH3 in the VZ. Moreover, the few MADM-11 cells were predominantly situated in the preplate (PPL) and all of these cells expressed both GFP and tdTom, suggesting that recombination had occurred during postmitotic stages of their development ([Fig. 3B](#f03){ref-type="fig"}). At E14.5, a few more recombined cells could be found in *Nestin-cre:MADM-11* cerebral cortices, but fewer clones could be detected in the VZ/SVZ compared to IZ/CP situated cells. Moreover, the majority of VZ/SVZ recombined cells were largely devoid of PH3 immunostaining ([Fig. 3C](#f03){ref-type="fig"}). By E17.5, recombination became sufficient in the entire cerebral cortex and PH3+ recombined cells in both VZ and SVZ regions could be readily detected ([Fig. 3C](#f03){ref-type="fig"}, arrows). These data confirm our finding that mitotic recombination (i.e., recombination in NSCs and NPCs) only becomes sufficient during perinatal development in the specific *Nestin-cre* line we obtained from the Jackson laboratory.

In summary, our study unraveled an important technical issue that has significant implications for neurodevelopmental investigators using the cre-lox technology as a genetic approach. We found that a readily utilized, and the only commercially available, *Nestin-cre* line of mice is a poor cre-driver for directing recombination to embryonic neural stem- and progenitor- cells. Recombination commences in the embryonic brain as reported in the past, but is largely confined to postmitotic neurons such as those occupying the preplate and cortical plate of the developing cortex. We think this discrepancy previously led many investigators to assume that the high rate of recombination includes progenitors in the VZ and SVZ of the developing central nervous system. However, we find that the rate of *Nestin-cre* driven recombination reaches nearly 100% in neural and glial progenitors during perinatal development. Whether or not this temporal gradient of recombination efficiency is a transgenic issue in the specific line of *Nestin-cre* mice used in our study, or if the endogenous *Nestin promoter* also exhibits a similar expression pattern remains to be determined. Temporal and spatial patterns of transgene expression have inherent problems including uncontrollable random copy number and integration site of the transgene (reviewed by [@b6]). For example, a transgene may be integrated into a locus that contains repressor sites or one with epigenetic modifications that do not favor transcription. It is also known that dynamic alterations occur in both transcriptional and epigenetic machinery in maturing NSCs ([@b9]). Hence, randomly integrated transgenes may be transcriptionally repressed in stem cells, but become active upon differentiation, or vice versa, as may be the case in the *Nestin-cre* line tested in this study. Thus, investigators planning to use the only *Nestin-cre* line of transgenic mice distributed by the Jackson Laboratory should take this technical limitation into consideration prior to utilizing it in their studies.
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